The FKBP51 Glucocorticoid Receptor Co-Chaperone: Regulation, Function, and Implications in Health and Disease.

Gabriel R Fries, Nils C Gassen, Theo Rein
Author Information
  1. Gabriel R Fries: Translational Psychiatry Program, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77054, USA. Gabriel.R.Fries@uth.tmc.edu.
  2. Nils C Gassen: Department of Translational Science in Psychiatry, Max Planck Institute of Psychiatry, 80804 Munich, Germany. ncgassen@psych.mpg.de.
  3. Theo Rein: Department of Translational Science in Psychiatry, Max Planck Institute of Psychiatry, 80804 Munich, Germany. theorein@psych.mpg.de. ORCID

Abstract

Among the chaperones and co-chaperones regulating the glucocorticoid receptor (GR), FK506 binding protein (FKBP) 51 is the most intensely investigated across different disciplines. This review provides an update on the role of the different co-chaperones of Hsp70 and Hsp90 in the regulation of GR function. The development leading to the focus on FKBP51 is outlined. Further, a survey of the vast literature on the mechanism and function of FKBP51 is provided. This includes its structure and biochemical function, its regulation on different levels-transcription, post-transcription, and post-translation-and its function in signaling pathways. The evidence portraying FKBP51 as a scaffolding protein organizing protein complexes rather than a chaperone contributing to the folding of individual proteins is collated. Finally, FKBP51's involvement in physiology and disease is outlined, and the promising efforts in developing drugs targeting FKBP51 are discussed.

Keywords

References

  1. Mol Cell Biol. 2006 Dec;26(23 ):8976-83 [PMID: 17000766]
  2. Cancer Cell. 2009 Sep 8;16(3):259-66 [PMID: 19732725]
  3. Brain Imaging Behav. 2017 Feb;11(1):62-75 [PMID: 26801675]
  4. Compr Psychiatry. 2014 Aug;55(6):1422-5 [PMID: 24889341]
  5. Bioorg Med Chem Lett. 2014 Jan 15;24(2):661-6 [PMID: 24360559]
  6. Biochem Biophys Res Commun. 2017 Apr 15;485(4):761-767 [PMID: 28254433]
  7. Biol Psychiatry. 2008 Jun 15;63(12):1103-10 [PMID: 18191112]
  8. J Biol Chem. 2002 May 31;277(22):19265-75 [PMID: 11877417]
  9. Psychol Med. 2012 May;42(5):943-56 [PMID: 21995950]
  10. J Immunol. 2012 May 1;188(9):4226-34 [PMID: 22474024]
  11. Behav Brain Res. 2017 Jan 15;317:46-61 [PMID: 27638035]
  12. Mol Biol Cell. 2010 May 1;21(9):1439-48 [PMID: 20237159]
  13. Cell Mol Life Sci. 2017 Sep 22;:null [PMID: 28939950]
  14. Cell Death Differ. 2010 Jan;17 (1):145-57 [PMID: 19696786]
  15. J Affect Disord. 2007 Dec;104(1-3):83-90 [PMID: 17467808]
  16. Mol Cell Biol. 2004 Apr;24(7):2682-97 [PMID: 15024059]
  17. Science. 1996 Dec 6;274(5293):1718-20 [PMID: 8939864]
  18. Biochim Biophys Acta. 2010 Jun;1803(6):641-9 [PMID: 20006655]
  19. J Biol Chem. 1996 Dec 13;271(50):32315-20 [PMID: 8943293]
  20. Nat Rev Drug Discov. 2004 Nov;3(11):950-64 [PMID: 15520817]
  21. Curr Mol Pharmacol. 2015 ;9(1):5-26 [PMID: 25986571]
  22. J Affect Disord. 2018 Jan 1;225:422-428 [PMID: 28850857]
  23. Transl Psychiatry. 2015 Sep 15;5:e636 [PMID: 26371764]
  24. PLoS One. 2014 Jan 14;9(1):e85415 [PMID: 24454860]
  25. Eur Arch Psychiatry Clin Neurosci. 2017 Mar;267(2):123-133 [PMID: 27549215]
  26. Nat Rev Mol Cell Biol. 2017 Mar;18(3):159-174 [PMID: 28053348]
  27. Int J Neuropsychopharmacol. 2014 Oct 31;18(1):null [PMID: 25522387]
  28. FEBS Lett. 2004 Feb 27;560(1-3):35-8 [PMID: 14987994]
  29. Trends Endocrinol Metab. 1998 Aug;9(6):244-52 [PMID: 18406276]
  30. Neuropsychopharmacology. 2000 Nov;23(5):477-501 [PMID: 11027914]
  31. Genes Brain Behav. 2017 Feb;16(2):223-232 [PMID: 27648526]
  32. J Affect Disord. 2010 Sep;125(1-3):249-55 [PMID: 20226536]
  33. Mol Cell Biol. 1998 Dec;18(12):7353-9 [PMID: 9819422]
  34. Curr Opin Pharmacol. 2011 Aug;11(4):288-93 [PMID: 21565553]
  35. Biochem J. 2005 May 1;387(Pt 3):789-96 [PMID: 15584899]
  36. PLoS One. 2014 Sep 05;9(9):e107241 [PMID: 25191701]
  37. J Biol Chem. 1985 Oct 15;260(23):12398-401 [PMID: 3900074]
  38. Psychiatr Danub. 2013 Sep;25(3):299-305 [PMID: 24048401]
  39. Comput Biol Chem. 2004 Apr;28(2):129-40 [PMID: 15130541]
  40. Neuropsychopharmacology. 2013 Feb;38(3):377-85 [PMID: 22990943]
  41. Depress Anxiety. 2016 Apr;33(4):300-7 [PMID: 27038411]
  42. Biochemistry. 2008 Sep 30;47(39):10471-80 [PMID: 18771283]
  43. Endocrinology. 2016 Oct;157(10 ):3888-3900 [PMID: 27442117]
  44. Trends Neurosci. 2008 Sep;31(9):464-8 [PMID: 18675469]
  45. J Mol Biol. 2001 May 11;308(4):795-806 [PMID: 11350175]
  46. PLoS One. 2013;8(2):e57508 [PMID: 23469007]
  47. Mol Genet Metab. 2011 Dec;104(4):457-69 [PMID: 21917492]
  48. Obes Res Clin Pract. 2016 Dec 19;:null [PMID: 28007534]
  49. Biochemistry. 2000 Nov 21;39(46):14314-21 [PMID: 11087380]
  50. Am J Med Genet B Neuropsychiatr Genet. 2007 Dec 5;144B(8):1097-8 [PMID: 17721930]
  51. Endocrinology. 2000 Nov;141(11):4107-13 [PMID: 11089542]
  52. Sci Rep. 2016 Sep 07;6:32687 [PMID: 27601205]
  53. Neuropsychopharmacology. 2010 Feb;35(3):727-40 [PMID: 19924111]
  54. J Immunol. 2016 Nov 15;197(10 ):3782-3791 [PMID: 27742828]
  55. Mol Endocrinol. 2007 Dec;21(12):2956-67 [PMID: 17717070]
  56. Cell Death Differ. 2009 Jul;16(7):1018-29 [PMID: 19390558]
  57. Front Neuroendocrinol. 2017 Jul;46:15-31 [PMID: 28502781]
  58. Mol Endocrinol. 2000 Jul;14(7):939-46 [PMID: 10894145]
  59. Neuropsychopharmacology. 2016 Jan;41(2):487-97 [PMID: 26076833]
  60. Cell Signal. 2004 Aug;16(8):857-72 [PMID: 15157665]
  61. Angew Chem Int Ed Engl. 2015 Jan 2;54(1):345-8 [PMID: 25412894]
  62. EMBO J. 2003 Mar 3;22(5):1158-67 [PMID: 12606580]
  63. Mol Cell. 2012 Feb 24;45(4):517-28 [PMID: 22365831]
  64. Cell Mol Life Sci. 2006 Nov;63(22):2560-70 [PMID: 16952052]
  65. J Mol Neurosci. 2015 Apr;55(4):951-8 [PMID: 25355489]
  66. Biochim Biophys Acta. 2012 Jul;1819(7):716-26 [PMID: 22425674]
  67. J Transl Med. 2011 Jan 14;9:8 [PMID: 21235734]
  68. Annu Rev Physiol. 2007;69:201-20 [PMID: 17137423]
  69. EMBO J. 2003 Jul 15;22(14):3613-23 [PMID: 12853476]
  70. Sci Rep. 2017 Oct 27;7(1):14288 [PMID: 29079741]
  71. J Psychopharmacol. 2016 Jan;30(1):40-7 [PMID: 26645208]
  72. Mol Cell. 2017 Sep 21;67(6):947-961.e5 [PMID: 28890336]
  73. Genome Biol Evol. 2013;5(12):2460-77 [PMID: 24277689]
  74. Endocrinology. 2008 Nov;149(11):5724-34 [PMID: 18669603]
  75. Nat Cell Biol. 2004 Feb;6(2):97-105 [PMID: 14743216]
  76. J Biol Chem. 2001 May 4;276(18):14884-9 [PMID: 11278753]
  77. J Biol Chem. 1998 Mar 27;273(13):7358-66 [PMID: 9516432]
  78. Biochem Biophys Res Commun. 2011 Jun 3;409(2):187-92 [PMID: 21565170]
  79. Gen Comp Endocrinol. 2001 Nov;124(2):152-65 [PMID: 11703081]
  80. J Biol Chem. 1978 Feb 10;253(3):856-65 [PMID: 621208]
  81. J Neurosci. 2015 Jun 17;35(24):9007-16 [PMID: 26085626]
  82. Mol Cell. 2005 Feb 4;17(3):367-79 [PMID: 15694338]
  83. Biol Psychiatry. 2016 Dec 1;80(11):869-877 [PMID: 26740367]
  84. Mol Cell Endocrinol. 2007 Sep 15;275(1-2):2-12 [PMID: 17628337]
  85. J Psychiatr Res. 2017 Jun;89:115-124 [PMID: 28246044]
  86. Cell Death Differ. 2016 Oct;23 (10 ):1579-91 [PMID: 27177020]
  87. J Neuroimmune Pharmacol. 2009 Jun;4(2):218-26 [PMID: 19199039]
  88. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:183-94 [PMID: 23733030]
  89. EMBO J. 2000 Nov 1;19(21):5930-40 [PMID: 11060043]
  90. PLoS One. 2014 Dec 17;9(12):e115135 [PMID: 25517604]
  91. F1000Res. 2017 Jul 24;6:1208 [PMID: 28781762]
  92. Depress Anxiety. 2017 Sep;34(9):845-855 [PMID: 28590587]
  93. Curr Alzheimer Res. 2013 Jan;10(1):72-81 [PMID: 23157339]
  94. J Biol Chem. 2005 Feb 11;280(6):4609-16 [PMID: 15591061]
  95. Psychoneuroendocrinology. 2011 Aug;36(7):1053-61 [PMID: 21316860]
  96. J Neurochem. 2010 Nov;115(3):716-34 [PMID: 20796173]
  97. Ann Hum Genet. 2014 Jul;78(4):290-8 [PMID: 24766650]
  98. FASEB J. 2007 Sep;21(11):2787-97 [PMID: 17435176]
  99. Int J Neuropsychopharmacol. 2010 Jun;13(5):649-60 [PMID: 20047716]
  100. Nat Chem Biol. 2015 Jan;11(1):33-7 [PMID: 25436518]
  101. Cell. 1995 Nov 17;83(4):589-98 [PMID: 7585962]
  102. Pharmacol Rev. 2006 Dec;58(4):685-704 [PMID: 17132848]
  103. J Biol Chem. 1999 Sep 17;274(38):26654-60 [PMID: 10480867]
  104. Mol Cancer. 2012 Aug 22;11:59 [PMID: 22913813]
  105. Trends Biochem Sci. 2017 May;42(5):355-368 [PMID: 28314505]
  106. Neuropsychopharmacology. 2012 May;37(6):1455-64 [PMID: 22237309]
  107. FEBS Lett. 2007 Jul 31;581(19):3702-10 [PMID: 17544402]
  108. Mol Cell Endocrinol. 2011 Mar 1;334(1-2):3-13 [PMID: 20615454]
  109. Trends Endocrinol Metab. 2011 Dec;22(12):481-90 [PMID: 21889356]
  110. FEBS Lett. 2009 May 6;583(9):1493-8 [PMID: 19375531]
  111. Biomed Res Int. 2014;2014:469278 [PMID: 24741566]
  112. Endocr Rev. 1997 Jun;18(3):306-60 [PMID: 9183567]
  113. Dev Psychopathol. 2016 May;28(2):385-97 [PMID: 26030911]
  114. Curr Top Med Chem. 2003;3(12):1348-57 [PMID: 12871166]
  115. Sci Signal. 2015 Nov 24;8(404):ra119 [PMID: 26602018]
  116. Brain Struct Funct. 2015;220(3):1355-68 [PMID: 24756342]
  117. Nat Commun. 2014 Nov 19;5:5484 [PMID: 25407331]
  118. J Biol Chem. 2003 Feb 14;278(7):4926-31 [PMID: 12482863]
  119. Cell Discov. 2016 Apr 05;2:16002 [PMID: 27462449]
  120. Endocrinology. 2006 Jan;147(1):590-8 [PMID: 16210365]
  121. Int J Psychiatry Clin Pract. 2016;20(2):106-15 [PMID: 26982819]
  122. Dev Psychopathol. 2012 Nov;24(4):1237-52 [PMID: 23062294]
  123. Science. 2002 Jun 21;296(5576):2232-5 [PMID: 12077419]
  124. Neurosignals. 2008;16(4):318-25 [PMID: 18635947]
  125. J Biol Chem. 2014 May 30;289(22):15297-308 [PMID: 24753260]
  126. Cell. 2000 Apr 14;101(2):199-210 [PMID: 10786835]
  127. PLoS One. 2011 Feb 09;6(2):e16883 [PMID: 21347384]
  128. Nature. 1990 Nov 8;348(6297):166-8 [PMID: 2234079]
  129. J Biol Chem. 2003 May 9;278(19):17228-35 [PMID: 12604615]
  130. Endocrinology. 2010 Sep;151(9):4332-43 [PMID: 20668026]
  131. Cell. 2005 Mar 11;120(5):715-27 [PMID: 15766533]
  132. Cell. 1991 Aug 23;66(4):807-15 [PMID: 1715244]
  133. Int J Neuropsychopharmacol. 2014 Dec 13;18(4):null [PMID: 25522420]
  134. Int J Cancer. 2016 Feb 15;138(4):797-808 [PMID: 25754838]
  135. Nat Rev Mol Cell Biol. 2017 Jun;18(6):345-360 [PMID: 28429788]
  136. Am J Psychiatry. 2011 Oct;168(10):1107-16 [PMID: 21865530]
  137. Autophagy. 2015 ;11(3):578-80 [PMID: 25714272]
  138. Clin Endocrinol (Oxf). 2015 Oct;83(4):441-8 [PMID: 25627931]
  139. Nat Neurosci. 2013 Jan;16(1):33-41 [PMID: 23201972]
  140. EMBO J. 1997 Oct 15;16(20):6209-16 [PMID: 9321400]
  141. Mol Cell. 2002 Dec;10(6):1307-18 [PMID: 12504007]
  142. J Neurosci. 2010 Jan 13;30(2):591-9 [PMID: 20071522]
  143. Int J Neuropsychopharmacol. 2016 Apr 20;19(4):null [PMID: 26721949]
  144. Trends Endocrinol Metab. 1997 Sep;8(7):271-5 [PMID: 18406815]
  145. J Cell Biol. 2017 Jul 3;216(7):1895-1906 [PMID: 28515275]
  146. Depress Anxiety. 2013 Dec;30(12):1170-6 [PMID: 23861224]
  147. Science. 1991 May 10;252(5007):839-42 [PMID: 1709302]
  148. Cell Stress Chaperones. 2004 Autumn;9(3):243-52 [PMID: 15544162]
  149. Nat Rev Genet. 2017 Oct 16;:null [PMID: 29033456]
  150. Front Mol Biosci. 2015 Apr 07;2:10 [PMID: 26913285]
  151. Psychoneuroendocrinology. 2016 Jul;69:98-105 [PMID: 27078785]
  152. J Steroid Biochem Mol Biol. 2016 Mar;157:3-6 [PMID: 25797032]
  153. Acta Crystallogr D Biol Crystallogr. 2011 Jun;67(Pt 6):549-59 [PMID: 21636895]
  154. Curr Opin Pharmacol. 2011 Aug;11(4):360-4 [PMID: 21498116]
  155. Behav Brain Res. 2017 May 15;325(Pt B):278-289 [PMID: 27485401]
  156. Nat Biotechnol. 2010 Jul;28(7):738-42 [PMID: 20581845]
  157. Am J Med Genet B Neuropsychiatr Genet. 2010 Mar 5;153B(2):554-560 [PMID: 19676097]
  158. Science. 1996 Dec 6;274(5293):1715-7 [PMID: 8939863]
  159. Proc Natl Acad Sci U S A. 1999 May 11;96(10):5452-7 [PMID: 10318904]
  160. Asian J Psychiatr. 2017 Jun;27:101-111 [PMID: 28558878]
  161. Cell Stress Chaperones. 2003 Summer;8(2):108-13 [PMID: 14627195]
  162. Cell. 2017 Apr 20;169(3):381-405 [PMID: 28431241]
  163. Nat Rev Mol Cell Biol. 2010 Jul;11(7):515-28 [PMID: 20531426]
  164. Sci Rep. 2014 Oct 21;4:6696 [PMID: 25331639]
  165. Mol Endocrinol. 2010 Mar;24(3):511-25 [PMID: 20093418]
  166. Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a001651 [PMID: 20457564]
  167. Surg Obes Relat Dis. 2016 Sep - Oct;12 (8):1560-1561 [PMID: 27444859]
  168. PLoS One. 2014 May 01;9(5):e95992 [PMID: 24788966]
  169. Pharmacogenomics. 2011 Mar;12(3):365-77 [PMID: 21449676]
  170. PLoS One. 2010 Jul 22;5(7):e11717 [PMID: 20661446]
  171. J Affect Disord. 2017 Sep 23;:null [PMID: 28969861]
  172. Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2876-81 [PMID: 14978266]
  173. J Biol Chem. 2017 Apr 28;292(17 ):7163-7172 [PMID: 28283576]
  174. Metabolism. 2014 Sep;63(9):1198-208 [PMID: 24997500]
  175. Cell. 2014 Jul 17;158(2):434-448 [PMID: 25036637]
  176. PLoS Med. 2014 Nov 11;11(11):e1001755 [PMID: 25386878]
  177. Proteins. 2018 Jan;86(1):43-56 [PMID: 29023988]
  178. Mol Neurobiol. 2016 May;53(4):2090-9 [PMID: 25912394]
  179. Health Psychol. 2014 Sep;33(9):1046-56 [PMID: 24099078]
  180. Cell. 2012 Aug 31;150(5):987-1001 [PMID: 22939624]
  181. Leukemia. 2004 Nov;18(11):1850-6 [PMID: 15385927]
  182. Depress Anxiety. 2011 Dec 21;28(12):1111-8 [PMID: 22134958]
  183. Gene. 2017 Sep 5;627:169-175 [PMID: 28629826]
  184. J Biol Chem. 1990 Mar 5;265(7):3996-4003 [PMID: 2303491]
  185. J Psychiatr Res. 2014 Nov;58:96-101 [PMID: 25088286]
  186. Sci Rep. 2017 Feb 15;7:42621 [PMID: 28198448]
  187. EMBO J. 2006 Jan 25;25(2):367-76 [PMID: 16407978]
  188. J Cell Biochem. 2002;84(3):460-71 [PMID: 11813252]
  189. EMBO J. 2000 Dec 1;19(23):6508-16 [PMID: 11101523]
  190. Acta Paediatr. 2015 Sep;104(9):910-5 [PMID: 26032970]
  191. Am J Physiol Endocrinol Metab. 2012 Apr 15;302(8):E987-91 [PMID: 22318949]
  192. J Biol Chem. 2002 Apr 5;277(14 ):11873-81 [PMID: 11809754]
  193. J Biol Chem. 2000 Oct 20;275(42):32775-82 [PMID: 10922363]
  194. Subcell Biochem. 2015;78:243-73 [PMID: 25487025]
  195. Cell. 2014 Jun 19;157(7):1685-97 [PMID: 24949977]
  196. Science. 1995 Jun 2;268(5215):1362-5 [PMID: 7761857]
  197. Mol Endocrinol. 1999 Mar;13(3):355-65 [PMID: 10076993]
  198. J Biol Chem. 1999 Jan 15;274(3):1432-9 [PMID: 9880517]
  199. Clin Biochem Rev. 2015 May;36(2):31-52 [PMID: 26224894]
  200. J Neurovirol. 2010 Oct;16(5):399-404 [PMID: 20726698]
  201. Mol Endocrinol. 2004 Jul;18(7):1620-30 [PMID: 15071092]
  202. J Biol Chem. 1995 Aug 11;270(32):18841-7 [PMID: 7642537]
  203. Mol Endocrinol. 2014 Aug;28(8):1265-75 [PMID: 24933247]
  204. Oncogene. 2010 Mar 18;29(11):1691-701 [PMID: 20023700]
  205. Mol Cell Endocrinol. 2004 Jan 15;213(2):131-8 [PMID: 15062560]
  206. Semin Cell Dev Biol. 2017 May;65:20-28 [PMID: 27235676]
  207. Psychoneuroendocrinology. 2015 Jan;51:426-30 [PMID: 25462914]
  208. Genes Brain Behav. 2013 Apr;12(3):289-96 [PMID: 23406438]
  209. Nat Rev Mol Cell Biol. 2013 Apr;14(4):237-48 [PMID: 23463216]
  210. Mol Neurobiol. 2017 Aug 18;:null [PMID: 28822116]
  211. Mol Psychiatry. 2016 Feb;21(2):277-89 [PMID: 25849320]
  212. J Biol Chem. 1998 May 1;273(18):10819-22 [PMID: 9556552]
  213. J Biol Chem. 2011 Dec 16;286(50):42911-22 [PMID: 21994940]
  214. Nat Cell Biol. 2001 Jan;3(1):93-6 [PMID: 11146632]
  215. J Affect Disord. 2014 Aug;164:33-7 [PMID: 24856550]
  216. Neuropsychopharmacology. 2011 Sep;36(10):1982-91 [PMID: 21654733]
  217. EMBO J. 2017 May 15;36(10 ):1434-1446 [PMID: 28363942]
  218. BMC Psychiatry. 2013 Aug 15;13:213 [PMID: 23945090]
  219. Bioessays. 2016 Sep;38(9):894-902 [PMID: 27374865]
  220. Sci Transl Med. 2016 Feb 10;8(325):325ra19 [PMID: 26865567]
  221. J Biol Chem. 2006 Mar 17;281(11):7161-71 [PMID: 16421106]
  222. Eur J Neurosci. 2008 Jul;28(2):389-98 [PMID: 18702710]
  223. Dev Psychopathol. 2014 Nov;26(4 Pt 2):1209-17 [PMID: 25422956]
  224. Blood. 2002 Oct 15;100(8):2932-40 [PMID: 12351405]
  225. Mol Cell Biol. 2007 Dec;27(24):8658-69 [PMID: 17938211]
  226. J Biol Chem. 2016 Aug 19;291(34):17897-906 [PMID: 27334923]
  227. EMBO Rep. 2008 Jun;9(6):536-42 [PMID: 18516089]
  228. Trends Biotechnol. 2003 Nov;21(11):498-503 [PMID: 14573363]
  229. J Biol Chem. 2003 Aug 29;278(35):32692-701 [PMID: 12788914]
  230. Biochem J. 2010 May 13;428(2):133-45 [PMID: 20462400]
  231. Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):E101; author reply E102 [PMID: 19020101]
  232. Pharmacogenomics. 2008 Jul;9(7):841-6 [PMID: 18597649]
  233. Transl Psychiatry. 2016 Oct 18;6(10 ):e925 [PMID: 27754486]
  234. Curr Mol Pharmacol. 2015 ;9(1):66-95 [PMID: 25986567]
  235. Pharmacogenet Genomics. 2013 Mar;23(3):156-66 [PMID: 23324805]
  236. J Cell Biol. 1999 Sep 6;146(5):929-40 [PMID: 10477749]
  237. Surg Obes Relat Dis. 2016 Sep - Oct;12 (8):1554-1560 [PMID: 27421688]
  238. Nat Genet. 2004 Dec;36(12):1319-25 [PMID: 15565110]
  239. Psychoneuroendocrinology. 2016 Apr;66:176-84 [PMID: 26821212]
  240. J Endocrinol. 2014 Jul;222(1):15-26 [PMID: 24781256]
  241. J Biol Chem. 1982 Dec 25;257(24):14949-59 [PMID: 7174676]
  242. Curr Mol Pharmacol. 2015 ;9(1):27-36 [PMID: 25986570]
  243. Mol Cell Biol. 2010 Mar;30(5):1243-53 [PMID: 20048054]
  244. Mol Oncol. 2016 Aug;10 (7):1086-98 [PMID: 27233944]
  245. Mol Endocrinol. 1998 Mar;12(3):342-54 [PMID: 9514152]
  246. Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8348-53 [PMID: 15159550]
  247. Genes Dev. 2000 Feb 15;14 (4):422-34 [PMID: 10691735]
  248. Behav Genet. 2012 Jan;42(1):121-32 [PMID: 21789663]
  249. Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):868-73 [PMID: 12538866]
  250. Cell Rep. 2016 Nov 8;17 (7):1882-1891 [PMID: 27829158]
  251. Curr Opin Pharmacol. 2011 Aug;11(4):308-13 [PMID: 21514887]
  252. Nat Rev Genet. 2014 Apr;15(4):234-46 [PMID: 24614316]

MeSH Term

Animals
Humans
Receptors, Glucocorticoid
Tacrolimus Binding Proteins

Chemicals

Receptors, Glucocorticoid
Tacrolimus Binding Proteins
tacrolimus binding protein 5

Word Cloud

Created with Highcharts 10.0.0FKBP51functionproteindifferentco-chaperonesglucocorticoidreceptorGRregulationoutlinedsignalingchaperoneAmongchaperonesregulatingFK506bindingFKBP51intenselyinvestigatedacrossdisciplinesreviewprovidesupdateroleHsp70Hsp90developmentleadingfocussurveyvastliteraturemechanismprovidedincludesstructurebiochemicallevels-transcriptionpost-transcriptionpost-translation-andpathwaysevidenceportrayingscaffoldingorganizingcomplexesrathercontributingfoldingindividualproteinscollatedFinallyFKBP51'sinvolvementphysiologydiseasepromisingeffortsdevelopingdrugstargetingdiscussedGlucocorticoidReceptorCo-Chaperone:RegulationFunctionImplicationsHealthDiseaseFKBP5drugpathway

Similar Articles

Cited By (64)